Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

5-Fluorouracil°ú BleomycinÀÌ »ç¶÷ÀÇ ±¸°­³» ¼¶À¯¸ð¼¼Æ÷¿¡ ¹ÌÄ¡´Â ¼¼Æ÷µ¶¼º¿¡ °üÇÑ ½ÇÇèÀû ¿¬±¸

An experimental study of the cytotoxic effects of 5-FU, and bleomycin on cultured human oral fibroBlasts

´ëÇѱ¸°­¾Ç¾È¸é¿Ü°úÇÐȸÁö 1992³â 18±Ç 2È£ p.61 ~ 64
±è¼º¼÷, ÃÖ±â·æ,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¼º¼÷ (  ) - ¿ø±¤´ëÇб³
ÃÖ±â·æ (  ) - ¿ø±¤´ëÇб³

Abstract

Ç×¾ÏÁ¦·Î »ç¿ëµÇ°í ÀÖ´Â 5-Fluorouracil(5-FU)°ú BleomycinÀÇ Á¤»ó ±¸°­³» ¼¶À¯ ¸ð¼¼Æ÷¿¡ ´ëÇÑ ¼¼Æ÷µ¶¼ºÀÇ ÃøÁ¤Àº ƯÁ¤ ¾Ï¼¼Æ÷¿¡ ´ëÇÑ ¾àÁ¦ÀÇ ¼¼Æ÷µ¶¼º°ú ÇÔ²² ¾àÁ¦ÀÇ ¼±ÅÃÀ̳ª ºÎÀÛ¿ëÀÇ Áø´Ü ¹× ¿¹¹æÀÇ Ãø¸é¿¡¼­ ¸Å¿ì Áß¿äÇÑ Àǹ̸¦ Áö´Ñ´Ù ÇÏ°Ú´Ù.
ÀÌ ¼¼Æ÷µ¶¼ºÀÇ ÃøÁ¤Àº Neutral red (NR)¿Í Tetrazolium MTT¸¦ »ç¿ëÇÏ¿© ±× Èí±¤µµ¸¦ ÃøÁ¤, ¿©·¯°¡Áö ³óµµ¿¡¼­ÀÇ 5-FU¿Í BleomycinÀÇ ¼¼Æ÷µ¶¼ºÀ» ÃøÁ¤ÇÏ¿© ´ÙÀ½°ú °°Àº °á·ÐÀ» ¾ò¾ú´Ù.
1. ¼¶À¯ ¸ð¼¼Æ÷ÀÇ NR°ú MTTÀÇ Èí¼ö´É·ÂÀº 5-FU¿Í BleomycinÀÇ ³óµµ°¡ Áõ°¡ÇÒ ¼ö·Ï °¨¼ÒÇÏ¿´´Ù.
2. 5-FU¿Í BleomycinÀÇ NR50°ªÀº 339.5, 422.5¥ì/mlÀ̸ç, MTT50°ªÀº 353.4, 303.5¥ìg/mlÀ¸·Î BorenfreundÀÇ ºÐ·ù¿¡ ÀÇÇÏ¸é °­ÇÑ µ¶¼ºÀ» ³ªÅ¸³»¾ú´Ù.
3. 5-FU¿Í BleomycinÀÇ NR90°ªÀº 41.5, 60.0¥ìg/mlÀ̸ç, MTT90°ªÀº 31.62, 26.2¥ìg/mlÀ̾ú´Ù.
4. À¯µµº¹ÇÕ¿ä¹ý(Inductive combination)ÀÇ NR50, MTT50°ªÀº 54.0, 44.2¥ìg/mlÀ̸ç, º¸Á¶ º¹ÇÕ¿ä¹ýÀº (Combination adjuvant) 56.0, 57.0¥ìg/ml·Î º¹ÇÕ¿ä¹ýÀÇ NR50, MTT50°ªÀÌ ´Üµ¶¿ä¹ýº¸´Ù ÇöÀúÇÏ°Ô ³·¾Ò´Ù.
5. ´Üµ¶¿ä¹ýÀº ÁߵÀÇ µ¶¼ºÀ» º¸¿´°í, º¹ÇÕ¿ä¹ýÀº °­ÇÑ µ¶¼ºÀ» º¸¿© ÇöÀúÇÑ ¼¼Æ÷µ¶¼ºÀÇ Â÷À̸¦ º¸¿´´Ù.
6. ¹è¾ç±¸°­ ¼¶À¯¸ð¼¼Æ÷¿¡¼­ 5-FU, À¯µµº¹ÇÕ¿ä¹ý(Inductive combination)°ú º¸Á¶ º¹ÇÕ¿ä¹ý(Combination adjuvant)Àº ´Ü¹éÁú »ý¼ºÀ» ¾ïÁ¦ÇÏÁö´Â ¾Ê¾ÒÀ¸³ª, BleomycinÀº ´Ü¹éÁú »ý¼ºÀ» ¾ïÁ¦ÇÏ¿´´Ù.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed